Curoverse
- Company typePrivate
- Founded2013
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Curoverse firmographics
Firmographics- Name
- Curoverse
- Legal name
- Curoverse, Inc.
- Website
- https://curoverse.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Curoverse industry classification
Industry- Product category
- Genomic and Biomedical Data Management Platform
- NAICS
- Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Data Virtualization & Federation (HDAEACAH)
- akta.pro secondary industry
- Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)
Keywords
Where Curoverse is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Curoverse business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Curoverse Cloud SaaS: Software-as-a-Service solution running Arvados in the cloud with free trial period (originally 6 months, now 3 months free storage and compute). Revenue generated through per-pipeline run charges and monthly subscription fees for continued usage.
- Curoverse Operations Subscription (COS): Similar to Red Hat subscriptions, provides software distributions, system administration support, training, full-stack patches and upgrades, and long-term maintenance for on-premise Arvados cluster deployments. Three-year guaranteed maintenance.
- Professional Services: Implementation services (planning through deployment), system integration, bioinformatics pipeline development, and data federation setup for Arvados clusters.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Trial - Cloud SaaS |
| Usage-based | Pay-as-you-go | Per Pipeline Run |
| Subscription | Monthly | Monthly Subscription |
| Subscription | Multi-year contract | Cluster Operation Subscription (COS) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Curoverse product offering
Product offeringCore offering
Curoverse provides commercially supported solutions built on Arvados, an open source computing platform for managing, processing, analyzing, and sharing genomic and biomedical data sets ranging from terabytes to petabytes. The platform combines a content-addressable storage system (Keep) with a containerized workflow engine (Crunch), and is offered as a cloud SaaS (Curoverse Cloud), as an on-premise cluster deployment (Curoverse Cluster), and as a multi-year support subscription (Cluster Operation Subscription) backed by implementation and professional services.
Product overview
Curoverse provides commercially supported solutions built on the Arvados open source platform. Arvados is a modern open source computing system for managing and processing terabytes to petabytes of genomic and biomedical data, combining content addressable storage (Keep) with a containerized workflow engine (Crunch). The commercial offering centers on the Cluster Operation Subscription (COS), which provides certified distributions, system administration support, end user support, training, 24/7 cluster administration services, and professional services for implementation, integration, and pipeline development. Deployment options include cloud and on-premise installations.
Differentiator
Problem solved
Functional benefit
Brands
- Arvados: Open source computing platform for managing and processing genomic and biomedical data, featuring content-addressable storage (Keep) and containerized workflow engine (Crunch).
Products and services
- Arvados Open source computing platform for managing and processing terabytes to petabytes of genomic and biomedical data, combining a content-addressable storage system (Keep) with a containerized workflow engine (Crunch). Available for on-premise or cloud deployment and used by research institutions, pharmaceutical companies, and clinical labs.
- Curoverse Cloud Software-as-a-Service offering that runs Arvados in the cloud, allowing bioinformaticians and researchers to upload data, access pre-built pipelines, and pay per pipeline run or via monthly subscriptions after a free trial period.
- Curoverse Cluster On-premise Arvados deployment option for organizations that want to run the platform on their own infrastructure, typically paired with the Cluster Operation Subscription for long-term maintenance and support.
- Cluster Operation Subscription (COS) Multi-year commercial support subscription for Arvados clusters, providing certified distributions, full-stack patches and upgrades, system administration support, end user support, training, and 24/7 cluster administration with a 3-year maintenance guarantee.
- Professional Services for Arvados Implementation and integration services covering the full deployment lifecycle, bioinformatics pipeline development, and data federation setup for Arvados clusters, delivered by the primary Arvados contributors.
Quantifiable outcome
- Increase utilization of existing HPC and cloud infrastructure
- +1 more outcomes
Companies that use Curoverse
Customer profileSegments3 records
Ideal customer profiles3 records
Curoverse technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature6 records
Curoverse partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Global Alliance for Genomics and HealthcoreCuroverse is a partner in the Global Alliance for Genomics and Health, an industry-wide body focused on crafting sustainable strategies for genomics and health data, compared to the W3C for semantic web standardization.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Curoverse competitors and assessment
Company assessmentDirect peers
- Lifebit: Direct competitor focused on federated genomics and biomedical data analysis. Their federated compute approach mirrors Curoverse's federated Arvados capability and targets similar pharma and research customers.
- DNAnexus: Direct competitor providing a cloud-based platform for managing, analyzing, and collaborating on genomic and biomedical data at scale. Both companies serve pharma, clinical labs, and research institutions with managed bioinformatics infrastructure.
- Genestack: Direct competitor providing a multi-omics data management and analysis platform with a focus on pharma and biobank customers. Comparable data integration and curation capabilities.
- BC Platforms: Direct competitor providing genomic data management and analytics platforms for pharma, research, and clinical customers with strong European footprint. Comparable commercial offering around genomic data infrastructure.
- Form Bio: Direct competitor spun out of DNAnexus founders offering a bioinformatics workflow platform. Provides similar computational pipeline and data management capabilities targeting life sciences researchers.
- Velsera (formerly Seven Bridges): Direct competitor offering a genomics and biomedical data analysis platform with similar cloud SaaS and on-prem deployment models. Targets the same pharma, clinical lab, and research customer segments as Curoverse.
Broad incumbents
- SOPHiA Genetics: Broad incumbent offering AI-driven genomic and clinical data analysis for hospitals and labs globally. While focused on clinical interpretation, it competes for the same clinical lab customer wallet as Curoverse.
- Illumina Connected Analytics: Broad incumbent from Illumina offering cloud-based genomic data management and analysis tightly integrated with their sequencing instruments. Competes for sequencing-driven infrastructure spend across clinical and research customers.
- AWS HealthOmics: Broad incumbent from Amazon Web Services offering managed genomic and biological data storage plus workflow execution as part of its broader cloud platform. Competes with Arvados for genomic infrastructure spend while bundling into a larger cloud portfolio.
- Google Cloud Life Sciences (Terra.bio): Broad incumbent partnership between Google Cloud and Verily providing genomic data analysis and biomedical research workflows. Competes on similar problem space as part of a much larger cloud and health analytics portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Curoverse social profiles
Digital presenceCuroverse compliance and trust
Trust signalCompliance3 records
Curoverse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curoverse leadership team
Management profileNumber of profiles
Profiles1 record
Curoverse funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curoverse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curoverse
What does Curoverse do?
Curoverse provides commercially supported solutions built on Arvados, an open source computing platform for managing, processing, analyzing, and sharing genomic and biomedical data sets ranging from terabytes to petabytes. The platform combines a content-addressable storage system (Keep) with a containerized workflow engine (Crunch), and is offered as a cloud SaaS (Curoverse Cloud), as an on-premise cluster deployment (Curoverse Cluster), and as a multi-year support subscription (Cluster Operation Subscription) backed by implementation and professional services.
Is Curoverse a public or private company?
Curoverse is a private company. It is classified as venture growth investor backed and is currently operating.
When was Curoverse founded?
Curoverse was founded in 2013. It employs 11 to 50 people.
Where is Curoverse based?
Curoverse is headquartered in Boston, United States, in the North America region.
How does Curoverse make money?
Three revenue lines are on record. Curoverse Cloud SaaS are the primary driver. The others are curoverse Operations Subscription (COS) and professional Services.
Who are Curoverse's main competitors?
Direct peers on record are Lifebit, DNAnexus, Genestack, BC Platforms, Form Bio and Velsera (formerly Seven Bridges). Broad incumbents are SOPHiA Genetics, Illumina Connected Analytics, AWS HealthOmics and Google Cloud Life Sciences (Terra.bio).
Does Curoverse have an API?
Yes. All Arvados services are accessed through a RESTful API. SDKs are available for Python, Perl, Ruby, Java, and Go. (R coming soon.)
What industry is Curoverse in?
Curoverse's product category is Genomic and Biomedical Data Management Platform. Its primary akta.pro industry code is HDAEACAH, Data Virtualization & Federation, with a secondary code of HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement). Its NAICS code is 513210 and its SIC code is 7372.